Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus
- PMID: 32944946
- PMCID: PMC7537028
- DOI: 10.1111/epi.16683
Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus
Abstract
There have been multiple descriptions of seizures during the acute infectious period in patients with COVID-19. However, there have been no reports of status epilepticus after recovery from COVID-19 infection. Herein, we discuss a patient with refractory status epilepticus 6 weeks after initial infection with COVID-19. Extensive workup demonstrated elevated inflammatory markers, recurrence of a positive nasopharyngeal SARS-CoV-2 polymerase chain reaction, and hippocampal atrophy. Postinfectious inflammation may have triggered refractory status epilepticus in a manner similar to the multisystemic inflammatory syndrome observed in children after COVID-19.
Keywords: COVID-19; SARS-CoV-2; inflammatory response; postinfectious; refractory status epilepticus; seizures.
© 2020 International League Against Epilepsy.
Conflict of interest statement
None of the authors has any conflict of interest to disclose.
Figures


References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous